Profile
Christopher Bird worked as the Head of North American Medical & Scientific Affairs at Roche Diagnostics Corp.
He then served as the Chief Medical Officer at Bioporto A from 2019 to 2023.
Dr. Bird holds a doctorate degree from the University of Oxford and undergraduate degrees from Brigham Young University, London Business School, and Escuela Superior de Administración y Dirección de Empresas.
He also has a graduate degree from the University of California Los Angeles Graduate School.
Former positions of Christopher Bird
Companies | Position | End |
---|---|---|
BIOPORTO A/S | Chief Tech/Sci/R&D Officer | 2022-12-31 |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Training of Christopher Bird
Brigham Young University | Undergraduate Degree |
University of California Los Angeles Graduate School | Graduate Degree |
University of Oxford | Doctorate Degree |
London Business School | Undergraduate Degree |
Escuela Superior de Administración y Dirección de Empresas | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BIOPORTO A/S | Health Technology |
Private companies | 1 |
---|---|
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |
- Stock Market
- Insiders
- Christopher Bird